F.D.A. Experts Will Vote on Safety of a Cure for Sickle Cell Disease

The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.

source https://www.nytimes.com/2023/10/30/health/sickle-cell-treatment-fda.html